Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07814560) titled 'Metabolic Syndrome and Risk of Chronic Philadelphia Negative Myeloproliferative Neoplasms' on Sept. 6.
Study Type: Observational
Primary Sponsor: Assiut University
Condition:
Philadelphia Chromosome Negative Chronic Myelogenous Leukemia
Recruitment Status: Not recruiting
Date of First Enrollment: December 1, 2026
Target Sample Size: 313
To know more, visit https://clinicaltrials.gov/study/NCT07814560
Published by HT Digital Content Services with permission from Health Daily Digest....